UPC CFI 674/2025

Jul 22, 2025·EP3167888 Unitary patent · TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

Case details: Status
Case Closed
Action
Generic
Category
Generic
Parties: Claimants
Samsung Bioepis NL B.V.Operating co.
Representatives
Peter Meyer-Simmons & Simmons
Respondents
Alexion Pharmaceuticals, Inc.Operating co.
Representatives
Elena Hennecke-Freshfields
Division: Hamburg LD
Judges: Sabine Klepsch
Alima Zana
Stefan Schilling
Rudi Goedeweeck
Technology: Chemistry
Biotechnology · Pharmaceuticals
Language: English
EPO Opposition: Samsung Bioepis NL B.V.Withdrawn2024-05-02
Amgen Technology (Ireland) Unlimited CompanyWithdrawn2024-10-28
Salute HC Ilaç Pazarlama A.S.Admissible2025-01-31

How this compares

How long the court takes to reach a first decision.

	Median days to first decision
All UPC	124
Hamburg LD	Locked
Judge Sabine Klepsch	Locked
Judge Alima Zana	Locked
Judge Stefan Schilling	Locked
Judge Rudi Goedeweeck	Locked

At the UPC: Samsung Group (57 cases)·AstraZeneca Group (13 cases)

Related cases

Documents